1. Home
  2. RDIB vs CNXU Comparison

RDIB vs CNXU Comparison

Compare RDIB & CNXU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Reading International Inc Class B

RDIB

Reading International Inc Class B

HOLD

Current Price

$19.88

Market Cap

204.5M

ML Signal

HOLD

Logo Conexeu Sciences Inc. Common Stock

CNXU

Conexeu Sciences Inc. Common Stock

N/A

Current Price

$7.08

Market Cap

215.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RDIB
CNXU
Founded
1937
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Movies/Entertainment
Industrial Specialties
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
204.5M
215.9M
IPO Year
1994
2025

Fundamental Metrics

Financial Performance
Metric
RDIB
CNXU
Price
$19.88
$7.08
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
399.0K
229.9K
Earning Date
05-14-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
60.76
N/A
EPS
N/A
N/A
Revenue
$202,988,000.00
N/A
Revenue This Year
$16.25
N/A
Revenue Next Year
$4.04
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.01
$6.85
52 Week High
$17.77
$13.66

Technical Indicators

Market Signals
Indicator
RDIB
CNXU
Relative Strength Index (RSI) 75.08 37.80
Support Level $10.47 N/A
Resistance Level $17.40 $10.41
Average True Range (ATR) 0.84 1.02
MACD 0.80 -0.14
Stochastic Oscillator 72.95 0.94

Price Performance

Historical Comparison
RDIB
CNXU

About RDIB Reading International Inc Class B

Reading International Inc is a diversified company, engaged in the development, ownership, and operation of multiplex cinemas and retail and commercial real estate in the United States, Australia, and New Zealand. It operates through two segments: the Cinema segment includes Reading Cinemas, Angelika Film Center, Consolidated Theatres, and City Cinemas; the Real Estate segment includes real estate development and the rental or licensing of retail, commercial and live theater assets.

About CNXU Conexeu Sciences Inc. Common Stock

Conexeu Sciences Inc is an early-stage medical technology company. The company develops and supplies collagen-based technologies that helps doctors and patients regenerate tissue naturally, safely, and effectively. The company is focused on developing regenerative biomaterials that address relative needs in wound care, dentistry, and aesthetics. The company seek to provide physicians with device-based solutions that improve healing, restore soft tissue, and enhance patient outcomes across multiple clinical settings. The company focuses durable, and growing addressable markets in regenerative aesthetics, wound care, 3D-printed tissue structures, veterinary wound repair, and dental soft-tissue regeneration.

Share on Social Networks: